Jason B. Daly, a vice president at Amneal Pharmaceuticals, Inc. ($AMRX), sold 210,000 shares on August 12, 2026. The open-market transaction was valued at $3.65 million, at $17.40 per share. Daly filed the Form 4 with the SEC on August 13, 2026, one day after the trade. He reported direct ownership of 35,171 shares afterward. At $17.40 per share, that remaining stake was worth about $612,000.
The August 12 sale was the larger of two in the filing. On August 11, 2026, Daly sold 6,613 shares at $17.70 per share for about $117,050. Across the two days, he sold 216,613 shares for roughly $3.77 million. Both were listed as open-market transactions, and the larger one accounted for $3.65 million of that total.
The August 2026 prices were higher than Daly's most recent prior $AMRX sale. On August 12, 2025, he sold 22,000 shares at $9.05 per share, a transaction of about $199,100, according to a Form 4 filed the following day. The database lists no other sales by Daly.
Daly was not the only Amneal insider to report a 2026 sale. Director Deborah M. Autor sold 34,819 shares on May 11, 2026, at $12.94 per share for about $450,558, disclosed in a Form 4 filed on May 12, 2026. Autor's May sale was also an open-market transaction. The 2026 $AMRX insider sales recorded in the database included two by Daly and one by Autor, totaling roughly $4.22 million.
Amneal Pharmaceuticals had a market capitalization of about $5.77 billion. The stock closed at $17.10 on August 11, 2026, and $17.66 on August 12, 2026. Daly's two sales were executed at $17.70 and $17.40 per share, respectively, on those days. The stock had closed at $18.46 on August 5, 2026, then traded in a closing range of $17.10 to $17.66 during the week of the sales. Volume on August 12 reached 3,322,867 shares, the highest level among the six sessions shown for early August.
Congressional STOCK Act records showed no $AMRX transactions after 2019. The most recent entries were two sales disclosed in June 2019 by Representatives Gilbert Cisneros and Josh Gottheimer, each listed at $1,001. Cisneros reported his sale on June 18, 2019; Gottheimer reported his on June 15, 2019. The Form 4 for Daly's August 2026 sales was filed the day after the transactions, matching the one-day disclosure lag on his August 2025 filing.